Big Rock Partners Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BRPA and buy or sell other stocks, ETFs, and their options commission-free!About BRPA
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt, MD
CEOJonathan C. Javitt, MD
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
BRPA Key Statistics
Market cap11.05M
Market cap11.05M
Price-Earnings ratio-0.84
Price-Earnings ratio-0.84
Dividend yield—
Dividend yield—
Average volume496.06K
Average volume496.06K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.01
52 Week high$6.01
52 Week low$1.21
52 Week low$1.21
Stock Snapshot
With a market cap of 11.05M, Big Rock Partners Acquisition(BRPA) trades at $0.40. The stock has a price-to-earnings ratio of -0.84.
During the trading day, Big Rock Partners Acquisition(BRPA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Big Rock Partners Acquisition(BRPA) stock has reached 0, versus its average volume of 496.06K.
The stock's 52-week range extends from a low of $1.21 to a high of $6.01.
The stock's 52-week range extends from a low of $1.21 to a high of $6.01.
People also own
Based on the portfolios of people who own BRPA. This list is generated using Robinhood data, and it’s not a recommendation.